HomeGLUE • NASDAQ
add
Monte Rosa Therapeutics Inc
Previous close
$5.99
Day range
$5.40 - $5.89
Year range
$3.21 - $12.40
Market cap
350.19M USD
Avg Volume
1.57M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 9.22M | — |
Operating expense | 10.23M | -3.88% |
Net income | -23.86M | 31.60% |
Net profit margin | -258.89 | — |
Earnings per share | -0.29 | 58.57% |
EBITDA | -24.42M | 30.48% |
Effective tax rate | -0.30% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 242.19M | 35.70% |
Total assets | 315.08M | 24.98% |
Total liabilities | 109.62M | 62.21% |
Total equity | 205.46M | — |
Shares outstanding | 61.44M | — |
Price to book | 1.79 | — |
Return on assets | -20.12% | — |
Return on capital | -25.60% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -23.86M | 31.60% |
Cash from operations | -20.99M | 15.02% |
Cash from investing | 37.75M | 5.95% |
Cash from financing | 15.00K | -98.64% |
Net change in cash | 16.77M | 39.48% |
Free cash flow | -4.29M | 69.42% |
About
Founded
2019
Headquarters
Website
Employees
133
